Timothy Dribin, MD, Lead Author on Study That Identifies Safe Discharge Window for Kids Seeking Treatment for Anaphylaxis

Timothy Dribin, MD, Lead Author on Study That Identifies Safe Discharge Window for Kids Seeking Treatment for Anaphylaxis

CCTST KL2 Scholar graduate, Timothy Dribin, MD, recently published a study in The Lancet: Child and Adolescent Health titled, “Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study”. Dr. Dribin, the lead author of the study, examined how children visiting emergency departments for allergic reactions can often be treated and safely discharged quickly – particularly those with epinephrine i…